{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:48Z","timestamp":1790800008397,"version":"4.1.0"},"reference-count":107,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":547,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/bjh.12804","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T09:55:29Z","timestamp":1393840529000},"page":"427-440","source":"Crossref","is-referenced-by-count":93,"title":["Gaucher disease: haematological presentations and complications"],"prefix":"10.1111","volume":"165","author":[{"given":"Alison S.","family":"Thomas","sequence":"first","affiliation":[{"name":"Lysosomal Storage Disorders Unit; Royal Free Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[{"name":"Lysosomal Storage Disorders Unit; Royal Free Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derralynn A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Lysosomal Storage Disorders Unit; Royal Free Hospital; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,3]]},"reference":[{"key":"10.1111\/bjh.12804-BIB0001|bjh12804-cit-0001","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-8674(78)90102-2","article-title":"Human beta-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells","volume":"15","author":"Achord","year":"1978","journal-title":"Cell"},{"key":"10.1111\/bjh.12804-BIB0002|bjh12804-cit-0002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Baillieres Clinical Haematology"},{"key":"10.1111\/bjh.12804-BIB0003|bjh12804-cit-0003","first-page":"205","article-title":"Cytokines in Gaucher's disease","volume":"10","author":"Barak","year":"1999","journal-title":"European Cytokine Network"},{"key":"10.1111\/bjh.12804-BIB0004|bjh12804-cit-0004","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1005655903139","article-title":"Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I","volume":"23","author":"Barone","year":"2000","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1111\/bjh.12804-BIB0005|bjh12804-cit-0005","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/bjh.12804-BIB0006|bjh12804-cit-0006","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ajh.2830400215","article-title":"High incidence of factor XI deficiency in Gaucher's disease","volume":"40","author":"Berrebi","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0007|bjh12804-cit-0007","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(70)91646-6","article-title":"Detection of the defect of Gaucher's disease and its carrier state in peripheral-blood leucocytes","volume":"1","author":"Beutler","year":"1970","journal-title":"Lancet"},{"key":"10.1111\/bjh.12804-BIB0008|bjh12804-cit-0008","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V76.3.646.646","article-title":"Misuse of marrow examination in the diagnosis of Gaucher disease","volume":"76","author":"Beutler","year":"1990","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0009|bjh12804-cit-0009","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"American Journal of Human Genetics"},{"key":"10.1111\/bjh.12804-BIB0010|bjh12804-cit-0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1096-8652(199603)51:3<234::AID-AJH9>3.0.CO;2-Y","article-title":"Coagulation abnormalities in patients with Gaucher's disease: effect of therapy","volume":"51","author":"Billett","year":"1996","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0011|bjh12804-cit-0011","doi-asserted-by":"crossref","first-page":"e57507","DOI":"10.1371\/journal.pone.0057507","article-title":"Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage","volume":"8","author":"Bohte","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/bjh.12804-BIB0012|bjh12804-cit-0012","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1976.03630040091019","article-title":"Factor IX deficiency in Gaucher disease. An in vitro phenomenon","volume":"136","author":"Boklan","year":"1976","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/bjh.12804-BIB0013|bjh12804-cit-0013","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1111\/bjh.12804-BIB0014|bjh12804-cit-0014","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1111\/bjh.12804-BIB0015|bjh12804-cit-0015","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1172\/JCI105417","article-title":"Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease","volume":"45","author":"Brady","year":"1966","journal-title":"Journal of Clinical Investigation"},{"key":"10.1111\/bjh.12804-BIB0016|bjh12804-cit-0016","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bcmd.2003.10.007","article-title":"Effect of enzyme replacement therapy on gammopathies in Gaucher disease","volume":"32","author":"Brautbar","year":"2004","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0017|bjh12804-cit-0017","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archinte.158.16.1754","article-title":"Gaucher disease: recommendations on diagnosis, evaluation, and monitoring","volume":"158","author":"Charrow","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/bjh.12804-BIB0018|bjh12804-cit-0018","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Archives of Internal Medicine"},{"key":"10.1111\/bjh.12804-BIB0019|bjh12804-cit-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochemistry International"},{"key":"10.1111\/bjh.12804-BIB0020|bjh12804-cit-0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Baillieres Clinical Haematology"},{"key":"10.1111\/bjh.12804-BIB0021|bjh12804-cit-0021","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/bjh.12804-BIB0022|bjh12804-cit-0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1750-1172-7-102","article-title":"Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study","volume":"7","author":"Cox","year":"2012","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1111\/bjh.12804-BIB0023|bjh12804-cit-0023","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/08880010600623232","article-title":"Coagulation abnormalities in type 1 Gaucher disease in children","volume":"23","author":"Deghady","year":"2006","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1111\/bjh.12804-BIB0024|bjh12804-cit-0024","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1182\/blood-2011-05-352971","article-title":"Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response","volume":"118","author":"Dekker","year":"2011","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0025|bjh12804-cit-0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1111\/bjh.12804-BIB0026|bjh12804-cit-0026","volume-title":"Refusal of the Marketing Authorisation for Elelyso (Taliglucerase alfa)","author":"European Medicines Agency","year":"2012"},{"key":"10.1111\/bjh.12804-BIB0027|bjh12804-cit-0027","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10545-008-0868-z","article-title":"Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry","volume":"31","author":"Fairley","year":"2008","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1111\/bjh.12804-BIB0028|bjh12804-cit-0028","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMp048363","article-title":"Orchestration of iron homeostasis","volume":"352","author":"Fleming","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/bjh.12804-BIB0029|bjh12804-cit-0029","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"Fost","year":"2006","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"10.1111\/bjh.12804-BIB0030|bjh12804-cit-0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00277-008-0441-8","article-title":"Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature","volume":"87","author":"Fost","year":"2008","journal-title":"Annals of Hematology"},{"key":"10.1111\/bjh.12804-BIB0031|bjh12804-cit-0031","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2012-07-442467","article-title":"Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease","volume":"121","author":"Franco","year":"2013","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0032|bjh12804-cit-0032","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0304-4165(81)90474-8","article-title":"Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation","volume":"673","author":"Furbish","year":"1981","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1111\/bjh.12804-BIB0033|bjh12804-cit-0033","unstructured":"Gaucher , P.C.E. 1882 De l'\u00e9pith\u00e9lioma primitif de la rate Facult\u00e9 de M\u00e9dicine de Paris"},{"key":"10.1111\/bjh.12804-BIB0034|bjh12804-cit-0034","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V","article-title":"Platelet function abnormalities in Gaucher disease patients","volume":"61","author":"Gillis","year":"1999","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0035|bjh12804-cit-0035","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1538-7836.2006.02037.x","article-title":"Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT)","volume":"4","author":"Giona","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1111\/bjh.12804-BIB0036|bjh12804-cit-0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2516.2011.02540.x","article-title":"Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease","volume":"18","author":"Givol","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/bjh.12804-BIB0037|bjh12804-cit-0037","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.23381","article-title":"Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: results from a randomized, double-blind, multinational, Phase 3 study","volume":"88","author":"Gonzalez","year":"2013","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0038|bjh12804-cit-0038","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbalip.2007.09.005","article-title":"Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells","volume":"1771","author":"Gouaze-Andersson","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1111\/bjh.12804-BIB0039|bjh12804-cit-0039","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/gte.1997.1.5","article-title":"Gaucher disease: gene frequencies and genotype\/phenotype correlations","volume":"1","author":"Grabowski","year":"1997","journal-title":"Genetic Testing"},{"key":"10.1111\/bjh.12804-BIB0040|bjh12804-cit-0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0223(200001)20:1<60::AID-PD763>3.0.CO;2-R","article-title":"Gaucher disease: considerations in prenatal diagnosis","volume":"20","author":"Grabowski","year":"2000","journal-title":"Prenatal Diagnosis"},{"key":"10.1111\/bjh.12804-BIB0041|bjh12804-cit-0041","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/bjh.12804-BIB0042|bjh12804-cit-0042","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1182\/blood-2011-11-387324","article-title":"Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics","volume":"119","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0043|bjh12804-cit-0043","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1148\/radiology.184.2.1620865","article-title":"Gaucher disease: abdominal MR imaging findings in 46 patients","volume":"184","author":"Hill","year":"1992","journal-title":"Radiology"},{"key":"10.1111\/bjh.12804-BIB0044|bjh12804-cit-0044","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1365-2141.1997.d01-2076.x","article-title":"Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy","volume":"96","author":"Hollak","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0045|bjh12804-cit-0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2141.2012.09175.x","article-title":"Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5\u00a0years","volume":"158","author":"Hollak","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0046|bjh12804-cit-0046","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2141.2007.06701.x","article-title":"Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease","volume":"138","author":"Hughes","year":"2007","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0047|bjh12804-cit-0047","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/bcmd.1998.0172","article-title":"Type 1 Gaucher disease: phenotypic expression and natural history in Japanese patients","volume":"24","author":"Ida","year":"1998","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0048|bjh12804-cit-0048","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcmd.2010.07.015","article-title":"Gaucher disease and dysgammaglobulinemia: a report of 61 patients, including 18 with GD type III","volume":"46","author":"Jurecka","year":"2011","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0049|bjh12804-cit-0049","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1083\/jcb.149.4.943","article-title":"Inhibition of cytokinesis by a lipid metabolite, psychosine","volume":"149","author":"Kanazawa","year":"2000","journal-title":"Journal of Cell Biology"},{"key":"10.1111\/bjh.12804-BIB0050|bjh12804-cit-0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood.V33.2.379.379","article-title":"Gaucher cells in chronic myelocytic leukemia: an acquired abnormality","volume":"33","author":"Kattlove","year":"1969","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0051|bjh12804-cit-0051","first-page":"188","article-title":"Increased operative bleeding during orthopaedic surgery in patients with type I Gaucher disease and bone involvement","volume":"58","author":"Katz","year":"1999","journal-title":"Bulletin\/Hospital for Joint Diseases"},{"key":"10.1111\/bjh.12804-BIB0052|bjh12804-cit-0052","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.47.2.162","article-title":"Acquired pseudo-pseudo Bernard-Soulier syndrome complicating Gaucher's disease","volume":"47","author":"Kelsey","year":"1994","journal-title":"Journal of Clinical Pathology"},{"key":"10.1111\/bjh.12804-BIB0053|bjh12804-cit-0053","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jbmr.1680","article-title":"Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry","volume":"27","author":"Khan","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/bjh.12804-BIB0054|bjh12804-cit-0054","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"American Journal of Human Genetics"},{"key":"10.1111\/bjh.12804-BIB0055|bjh12804-cit-0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"QJM"},{"key":"10.1111\/bjh.12804-BIB0056|bjh12804-cit-0056","doi-asserted-by":"crossref","first-page":"e69293","DOI":"10.1371\/journal.pone.0069293","article-title":"A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients","volume":"8","author":"Lecourt","year":"2013","journal-title":"PLoS One"},{"key":"10.1111\/bjh.12804-BIB0057|bjh12804-cit-0057","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1073\/pnas.1200941109","article-title":"Gaucher disease gene GBA functions in immune regulation","volume":"109","author":"Liu","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/bjh.12804-BIB0058|bjh12804-cit-0058","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.21684","article-title":"Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types - correlation with genotype and phenotype","volume":"85","author":"Lo","year":"2010","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0059|bjh12804-cit-0059","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1182\/blood-2010-06-293902","article-title":"Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0060|bjh12804-cit-0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1111\/bjh.12804-BIB0061|bjh12804-cit-0061","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1005655031239","article-title":"The natural course of Gaucher disease in The Netherlands: implications for monitoring of disease manifestations","volume":"23","author":"Maaswinkel-Mooij","year":"2000","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1111\/bjh.12804-BIB0062|bjh12804-cit-0062","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/bjh.12804-BIB0063|bjh12804-cit-0063","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: from human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1111\/bjh.12804-BIB0064|bjh12804-cit-0064","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1111\/bjh.12804-BIB0065|bjh12804-cit-0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/1097-0142(19950115)75:2<577::AID-CNCR2820750222>3.0.CO;2-K","article-title":"Cancer risk after splenectomy","volume":"75","author":"Mellemkjoer","year":"1995","journal-title":"Cancer"},{"key":"10.1111\/bjh.12804-BIB0066|bjh12804-cit-0066","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy","volume":"77","author":"Mistry","year":"2002","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1111\/bjh.12804-BIB0067|bjh12804-cit-0067","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0068|bjh12804-cit-0068","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2141.2009.07872.x","article-title":"Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis","volume":"147","author":"Mistry","year":"2009","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0069|bjh12804-cit-0069","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/bjh.12804-BIB0070|bjh12804-cit-0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcmd.2012.03.003","article-title":"Markers of coagulation activation and enhanced fibrinolysis in Gaucher type 1 patient: effects of enzyme replacement therapy","volume":"49","author":"Mitrovic","year":"2012","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0071|bjh12804-cit-0071","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/bmj.286.6381.1864","article-title":"Serum ferritin concentration in Gaucher's disease","volume":"286","author":"Morgan","year":"1983","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1111\/bjh.12804-BIB0072|bjh12804-cit-0072","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<28::AID-AJH5>3.0.CO;2-5","article-title":"Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients","volume":"55","author":"Neudorfer","year":"1997","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0073|bjh12804-cit-0073","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbagen.2012.04.008","article-title":"Globoside promotes activation of ERK by interaction with the epidermal growth factor receptor","volume":"1820","author":"Park","year":"2012","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1111\/bjh.12804-BIB0074|bjh12804-cit-0074","first-page":"151","article-title":"Pathology of the Gaucher cell","volume":"95","author":"Parkin","year":"1982","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1111\/bjh.12804-BIB0075|bjh12804-cit-0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Seminars in Hematology"},{"key":"10.1111\/bjh.12804-BIB0076|bjh12804-cit-0076","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.4227","article-title":"B cell lymphoma and myeloma in murine Gaucher's disease","volume":"231","author":"Pavlova","year":"2013","journal-title":"Journal of Pathology"},{"key":"10.1111\/bjh.12804-BIB0077|bjh12804-cit-0077","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2004.09.004","article-title":"Enhanced calcium release in the acute neuronopathic form of Gaucher disease","volume":"18","author":"Pelled","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1111\/bjh.12804-BIB0078|bjh12804-cit-0078","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/bjh.12804-BIB0079|bjh12804-cit-0079","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood.V31.5.633.633","article-title":"Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases","volume":"31","author":"Pratt","year":"1968","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0080|bjh12804-cit-0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.1999.01705.x","article-title":"Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells","volume":"107","author":"Puthier","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0081|bjh12804-cit-0081","first-page":"357","article-title":"Inhibitors and stimulators of glucocerebroside metabolism","volume":"95","author":"Radin","year":"1982","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1111\/bjh.12804-BIB0082|bjh12804-cit-0082","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0083|bjh12804-cit-0083","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00007890-198807000-00011","article-title":"Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease","volume":"46","author":"Ringden","year":"1988","journal-title":"Transplantation"},{"key":"10.1111\/bjh.12804-BIB0084|bjh12804-cit-0084","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bcmd.2012.11.012","article-title":"Gammopathy and B lymphocyte clonality in patients with Gaucher type I disease","volume":"50","author":"Rodic","year":"2013","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0085|bjh12804-cit-0085","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1111\/bjh.12804-BIB0086|bjh12804-cit-0086","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0087|bjh12804-cit-0087","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/GIM.0b013e318195e2b6","article-title":"Multiple myeloma and Gaucher genes","volume":"11","author":"Rosenbloom","year":"2009","journal-title":"Genetics in Medicine"},{"key":"10.1111\/bjh.12804-BIB0088|bjh12804-cit-0088","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00000658-197911000-00006","article-title":"Splenectomy for Gaucher's disease","volume":"190","author":"Salky","year":"1979","journal-title":"Annals of Surgery"},{"key":"10.1111\/bjh.12804-BIB0089|bjh12804-cit-0089","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/17446651.2013.846213","article-title":"Eliglustat tartrate, a prototypic glucosylceramide synthase inhibitor","volume":"8","author":"Shayman","year":"2013","journal-title":"Expert Review of Endocrinology & Metabolism"},{"key":"10.1111\/bjh.12804-BIB0090|bjh12804-cit-0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","article-title":"Increased risk of cancer in patients with Gaucher disease","volume":"72","author":"Shiran","year":"1993","journal-title":"Cancer"},{"key":"10.1111\/bjh.12804-BIB0091|bjh12804-cit-0091","first-page":"388","article-title":"Gaucher's disease: a disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"10.1111\/bjh.12804-BIB0092|bjh12804-cit-0092","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1111\/bjh.12804-BIB0093|bjh12804-cit-0093","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.2011.08613.x","article-title":"Platelet adhesion defect in type I Gaucher disease is associated with a risk of mucosal bleeding","volume":"153","author":"Spectre","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.12804-BIB0094|bjh12804-cit-0094","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1111\/bjh.12804-BIB0095|bjh12804-cit-0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10545-010-9175-6","article-title":"Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy","volume":"33","author":"Stein","year":"2010a","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1111\/bjh.12804-BIB0096|bjh12804-cit-0096","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","article-title":"Hyperferritinemia and iron overload in type 1 Gaucher disease","volume":"85","author":"Stein","year":"2010b","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0097|bjh12804-cit-0097","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/auto.6.5.12047","article-title":"Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease","volume":"6","author":"Sun","year":"2010","journal-title":"Autophagy"},{"key":"10.1111\/bjh.12804-BIB0098|bjh12804-cit-0098","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"American Journal of Hematology"},{"key":"10.1111\/bjh.12804-BIB0099|bjh12804-cit-0099","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bcmd.2012.11.004","article-title":"Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists","volume":"50","author":"Thomas","year":"2013","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0100|bjh12804-cit-0100","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1182\/blood.V82.12.3712.3712","article-title":"Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion","volume":"82","author":"Uchiyama","year":"1993","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0101|bjh12804-cit-0101","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5\u00a0years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"American Journal of Medicine"},{"key":"10.1111\/bjh.12804-BIB0102|bjh12804-cit-0102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/bjh.12804-BIB0103|bjh12804-cit-0103","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10245330500067181","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005a","journal-title":"Hematology"},{"key":"10.1111\/bjh.12804-BIB0104|bjh12804-cit-0104","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005b","journal-title":"Blood Cells, Molecules, & Diseases"},{"key":"10.1111\/bjh.12804-BIB0105|bjh12804-cit-0105","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-02-268649","article-title":"Phase 1\/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience","volume":"115","author":"Zimran","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0106|bjh12804-cit-0106","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"10.1111\/bjh.12804-BIB0107|bjh12804-cit-0107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells, Molecules, & Diseases"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.12804","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjh.12804\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:38:36Z","timestamp":1716575916000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.12804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,3]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjh.12804","relation":{},"ISSN":["0007-1048"],"issn-type":[{"value":"0007-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,3]]}}}